Intestinally Targeted Diacylglycerol Acyltransferase 1 (DGAT1) Inhibitors Robustly Suppress Postprandial TriglyceridesMichael H. Serrano‐Wu, Brian K. Hubbard, Renee Commerford et al.|ACS Medicinal Chemistry Letters|2012Cited by 27
Discovery of an Orally Bioavailable Benzimidazole Diacylglycerol Acyltransferase 1 (DGAT1) Inhibitor That Suppresses Body Weight Gain in Diet-Induced Obese Dogs and Postprandial Triglycerides in HumansKatsumasa Nakajima, Michael H. Serrano‐Wu, Ricardo E. Chatelain et al.|Journal of Medicinal Chemistry|2017Cited by 18
Discovery of diamide compounds as diacylglycerol acyltransferase 1 (DGAT1) inhibitorsKatsumasa Nakajima, Bing Wang, Myriam April et al.|Bioorganic & Medicinal Chemistry Letters|2016Cited by 5